Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accrual, adenine, adverselyaffected, alleviated, Ameliorate, Boca, claimant, collateral, cumulative, CVCapital, cycle, daily, dedicate, dinucleotide, disadvantage, Disani, dollar, Dongmyung, dose, drawn, earliest, entity, exceptionally, fewer, figure, footnote, foreclose, frequency, fundamental, healthy, Highway, inducing, insufficient, intensify, intermediate, IRA, Journal, lending, loan, main, maturity, Memory, metabolome, mortgage, noncurrent, nonpublic, optimize, organizational, OTCQX, prepay, prepayment, principle, PURENERGY, Raton, refinance, reorganization, retrospective, rice, saving, settle, strive, style, Subtopic, supersede, synergistic, Toni, top, Toronto, traveling, TSX, turnover, unaccounted, vendor, vulnerable, wereinfringed, Withoutthese
Removed:
approximate, Becvar, binomial, campaign, capability, ceased, Cody, commercialized, compliant, confidence, Debra, deducting, dilutive, documentation, estimation, half, Heim, Himmel, impacted, incorporation, incremental, internet, invest, Jeffrey, Latin, opko, partnering, radio, remediation, retailer, Spengler, tabulation, William
Filing tables
Filing exhibits
- 10-K Annual report
- 10.39 Loan and Security Agreement by and Between Chromadex Corporation and Hercules Technology II, L.P., As Lender and Hercules Technology Growth Capital, Inc., As Agent Dated September 29, 2014
- 10.40 License Agreement, Effective As of October 15, 2014 Between University of Mississippi and Chromadex, Inc.
- 10.41 Transfer and Notice of Conversion by Chromadex Corporation, Alpha Capital Anstalt and Palladium Capital Advisors, LLC, and by Neutrisci International Inc. and Disani Capital Corp. Executed on November 26, 2014
- 10.42 Share Transfer Agreement by and Between Chromadex Corporation and Emprise Capital Corporation Dated November 25, 2014
- 23.1 Consent of Marcum, LLP, Independent Registered Public Accounting Firm
- 31.1 Certification of the Chief Executive Officer Pursuant to ?240.13A-14 or ?240.15D-14 of the Securities Exchange Act of 1934, As Amended
- 31.2 Certification of the Chief Financial Officer Pursuant to ?240.13A-14 or ?240.15D-14 of the Securities Exchange Act of 1934, As Amended
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350 (As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002)
- Download Excel data file
- View Excel data file
CDXC similar filings
Filing view
External links
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in the Registration Statements of ChromaDex Corporation and Subsidiaries on Form S-8 [File No. 333-196434, File No. 333-168029, File No. 333-154402, and File No. 333-154403] of our report dated March 19, 2015, with respect to our audits of the consolidated financial statements of ChromaDex Corporation and Subsidiaries as of January 3, 2015 and December 28, 2013 and for the years ended January 3, 2015 and December 28, 2013 and our report dated March 19, 2015 with respect to our audit of the effectiveness of internal control over financial reporting of ChromaDex Corporation and Subsidiaries as of January 3, 2015, which reports are included in this Annual Report on Form 10-K of ChromaDex Corporation and Subsidiaries for the year ended January 3, 2015.
/s/ Marcum llp
Marcum llp
New York, NY
March 19, 2015